Published in Eur J Immunol on February 01, 2005
Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am J Pathol (2007) 5.27
Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J Exp Med (2007) 3.68
Neonatal innate TLR-mediated responses are distinct from those of adults. J Immunol (2009) 3.29
IL-23-dependent IL-17 production is essential in neutrophil recruitment and activity in mouse lung defense against respiratory Mycoplasma pneumoniae infection. Microbes Infect (2006) 2.39
Host and bacterial factors contributing to the clearance of colonization by Streptococcus pneumoniae in a murine model. Infect Immun (2005) 2.32
The dual nature of T(H)17 cells: shifting the focus to function. Nat Immunol (2010) 1.78
Cells of the synovium in rheumatoid arthritis. T lymphocytes. Arthritis Res Ther (2007) 1.63
Macrophage cytokines: involvement in immunity and infectious diseases. Front Immunol (2014) 1.44
IL-23 induces human osteoclastogenesis via IL-17 in vitro, and anti-IL-23 antibody attenuates collagen-induced arthritis in rats. Arthritis Res Ther (2007) 1.40
Stat4-dependent, T-bet-independent regulation of IL-10 in NK cells. Genes Immun (2008) 1.26
Serum levels of IL-17 and IL-22 are reduced by etanercept, but not by acitretin, in patients with psoriasis: a randomized-controlled trial. J Clin Immunol (2008) 1.18
Roles of pro- and anti-inflammatory cytokines in the pathogenesis of SLE. J Biomed Biotechnol (2012) 1.06
Increased circulating interleukin (IL)-23 in children with malarial anemia: in vivo and in vitro relationship with co-regulatory cytokines IL-12 and IL-10. Clin Immunol (2007) 0.96
Interleukin-17A mRNA and protein expression within cells from the human bronchoalveolar space after exposure to organic dust. Respir Res (2005) 0.93
Ustekinumab: differential use in psoriasis. Clin Cosmet Investig Dermatol (2011) 0.91
Unbalanced Neonatal CD4(+) T-Cell Immunity. Front Immunol (2014) 0.87
CD8(+) T cells in multiple sclerosis. Expert Opin Ther Targets (2013) 0.86
Exosome Secretion by the Parasitic Protozoan Leishmania within the Sand Fly Midgut. Cell Rep (2015) 0.85
MOG(35-55) i.v suppresses experimental autoimmune encephalomyelitis partially through modulation of Th17 and JAK/STAT pathways. Eur J Immunol (2009) 0.81
Cigarette smoke activates the proto-oncogene c-src to promote airway inflammation and lung tissue destruction. Am J Respir Cell Mol Biol (2014) 0.81
Interleukin-12 is the optimum cytokine to expand human Th17 cells in vitro. Clin Vaccine Immunol (2009) 0.81
Brodalumab: an evidence-based review of its potential in the treatment of moderate-to-severe psoriasis. Core Evid (2014) 0.80
The WSX-1 pathway restrains intestinal T-cell immunity. Int Immunol (2011) 0.80
Update on pathogenesis and predictors of response of therapeutic strategies used in inflammatory bowel disease. World J Gastroenterol (2015) 0.79
Pleural mesothelial cells promote expansion of IL-17-producing CD8+ T cells in tuberculous pleural effusion. J Clin Immunol (2013) 0.79
Cytokine gene expression in the skin and peripheral blood of atopic dermatitis patients and healthy individuals. Self Nonself (2011) 0.78
IL-23 activates innate lymphoid cells to promote neonatal intestinal pathology. Mucosal Immunol (2014) 0.77
Biologics in dermatology: an integrated review. Indian J Dermatol (2014) 0.75
Effect of inhibition of interleukin-12/23 by ustekinumab on the expression of leptin and leptin receptor in human THP-1 macrophages. Clin Exp Dermatol (2015) 0.75
Emerging treatments in the management of psoriasis: biological targeting with ustekinumab. Clin Cosmet Investig Dermatol (2009) 0.75
[How do T-cells become activated in joints?]. Z Rheumatol (2010) 0.75
Age-Stratified T Cell Responses in Children Infected with Mycobacterium tuberculosis. Front Immunol (2017) 0.75
IL-23 and Th17 Disease in Inflammatory Arthritis. J Clin Med (2017) 0.75
Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med (2005) 10.16
Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J Clin Invest (2010) 3.41
IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection. J Immunol (2004) 2.59
Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly. Immunity (2012) 2.08
Lymphocytic variant hypereosinophilic syndromes. Immunol Allergy Clin North Am (2007) 1.85
Impaired responses to toll-like receptor 4 and toll-like receptor 3 ligands in human cord blood. J Autoimmun (2003) 1.74
A defect in nucleosome remodeling prevents IL-12(p35) gene transcription in neonatal dendritic cells. J Exp Med (2004) 1.71
Critical influence of natural regulatory CD25+ T cells on the fate of allografts in the absence of immunosuppression. Transplantation (2005) 1.66
How microorganisms tip the balance between interleukin-12 family members. Nat Rev Immunol (2008) 1.65
Early immunosuppression withdrawal after living donor liver transplantation and donor stem cell infusion. Liver Transpl (2006) 1.57
Cytokine mRNA quantification by real-time PCR. J Immunol Methods (2002) 1.56
Hypereosinophilic syndromes. Orphanet J Rare Dis (2007) 1.53
Double-stranded RNAs from the helminth parasite Schistosoma activate TLR3 in dendritic cells. J Biol Chem (2004) 1.44
Human cytomegalovirus elicits fetal gammadelta T cell responses in utero. J Exp Med (2010) 1.39
Acquisition of adult-like TLR4 and TLR9 responses during the first year of life. PLoS One (2010) 1.37
Monophosphoryl lipid A activates both human dendritic cells and T cells. J Immunol (2002) 1.36
Preferential production of the IL-12(p40)/IL-23(p19) heterodimer by dendritic cells from human newborns. Eur J Immunol (2006) 1.35
High serum thymus and activation-regulated chemokine levels in the lymphocytic variant of the hypereosinophilic syndrome. J Allergy Clin Immunol (2002) 1.34
Critical role of regulatory T cells in Th17-mediated minor antigen-disparate rejection. J Immunol (2010) 1.34
Blood plasmacytoid dendritic cell responses to CpG oligodeoxynucleotides are impaired in human newborns. Blood (2003) 1.32
Human gamma delta T cells induce dendritic cell maturation. Clin Immunol (2002) 1.29
Induction of FOXP3-expressing regulatory CD4pos T cells by human mature autologous dendritic cells. Eur J Immunol (2004) 1.27
Nicotine protects kidney from renal ischemia/reperfusion injury through the cholinergic anti-inflammatory pathway. PLoS One (2007) 1.27
IL-27 synthesis induced by TLR ligation critically depends on IFN regulatory factor 3. J Immunol (2007) 1.26
Mepolizumab as a corticosteroid-sparing agent in lymphocytic variant hypereosinophilic syndrome. J Allergy Clin Immunol (2010) 1.25
The hypereosinophilic syndrome revisited. Annu Rev Med (2001) 1.25
Interferon regulatory factor 7-mediated responses are defective in cord blood plasmacytoid dendritic cells. Eur J Immunol (2008) 1.24
Vaccination and autoimmune disease: what is the evidence? Lancet (2003) 1.22
Multiple pathways to allograft rejection. Transplantation (2002) 1.21
Interferon regulatory factor 3 is involved in Toll-like receptor 4 (TLR4)- and TLR3-induced IL-12p35 gene activation. Blood (2005) 1.20
Human IL-12(p35) gene activation involves selective remodeling of a single nucleosome within a region of the promoter containing critical Sp1-binding sites. Blood (2003) 1.19
Myocardial homing of nonmobilized peripheral-blood CD34+ cells after intracoronary injection. Stem Cells (2005) 1.19
Inhibition of phosphoinositide 3-kinase enhances TRIF-dependent NF-kappa B activation and IFN-beta synthesis downstream of Toll-like receptor 3 and 4. Eur J Immunol (2005) 1.17
Antigen-specific central memory CD4+ T lymphocytes produce multiple cytokines and proliferate in vivo in humans. J Immunol (2006) 1.17
Interferon regulatory factor 3-dependent responses to lipopolysaccharide are selectively blunted in cord blood cells. Blood (2007) 1.17
Inflammation modifies the pattern and the function of Toll-like receptors expressed by human mesenchymal stromal cells. Hum Immunol (2010) 1.17
Critical role of the IFN-stimulated gene factor 3 complex in TLR-mediated IL-27p28 gene expression revealing a two-step activation process. J Immunol (2010) 1.15
Double-stranded RNA induces pancreatic beta-cell apoptosis by activation of the toll-like receptor 3 and interferon regulatory factor 3 pathways. Diabetes (2008) 1.14
Fostering responsible data sharing through standards. N Engl J Med (2014) 1.11
CD4+CD25+ and CD4+CD25- T cells act respectively as inducer and effector T suppressor cells in superantigen-induced tolerance. J Immunol (2003) 1.10
Molecular profiling of CD3-CD4+ T cells from patients with the lymphocytic variant of hypereosinophilic syndrome reveals targeting of growth control pathways. Blood (2009) 1.07
Protein kinase C epsilon: a new target to control inflammation and immune-mediated disorders. Int J Biochem Cell Biol (2004) 1.05
Toll-like receptor (TLR)2 and TLR3 synergy and cross-inhibition in murine myeloid dendritic cells. Immunol Lett (2007) 1.04
Anaphylactic shock caused by immunoglobulin E sensitization after retreatment with the chimeric anti-interleukin-2 receptor monoclonal antibody basiliximab. Transplantation (2003) 1.04
Interleukin-12 family members and the balance between rejection and tolerance. Curr Opin Organ Transplant (2008) 1.04
Crucial role of gamma interferon-producing CD4+ Th1 cells but dispensable function of CD8+ T cell, B cell, Th2, and Th17 responses in the control of Brucella melitensis infection in mice. Infect Immun (2012) 1.02
Immune monitoring in whole blood using real-time PCR. J Immunol Methods (2003) 1.02
Thrombospondin-1 and indoleamine 2,3-dioxygenase are major targets of extracellular ATP in human dendritic cells. Blood (2005) 1.02
6q- is an early and persistent chromosomal aberration in CD3-CD4+ T-cell clones associated with the lymphocytic variant of hypereosinophilic syndrome. Haematologica (2005) 1.01
Hypereosinophilic syndrome: lymphoproliferative and myeloproliferative variants. Semin Respir Crit Care Med (2006) 1.01
The multiple facets of toll-like receptors in transplantation biology. Transplantation (2008) 0.99
Tristetraprolin regulation of interleukin 23 mRNA stability prevents a spontaneous inflammatory disease. J Exp Med (2013) 0.99
Toll-like receptor (TLR)2 and TLR3 sensing is required for dendritic cell activation, but dispensable to control Schistosoma mansoni infection and pathology. Microbes Infect (2007) 0.98
111In-oxine and 99mTc-HMPAO labelling of antigen-loaded dendritic cells: in vivo imaging and influence on motility and actin content. Eur J Nucl Med Mol Imaging (2003) 0.98
Extracellular adenine nucleotides modulate cytokine production by human monocyte-derived dendritic cells: dual effect on IL-12 and stimulation of IL-10. Eur J Immunol (2002) 0.98
PKC-alpha controls MYD88-dependent TLR/IL-1R signaling and cytokine production in mouse and human dendritic cells. Eur J Immunol (2010) 0.98
Distribution and regulation of expression of the putative human chemokine receptor HCR in leukocyte populations. Eur J Immunol (2002) 0.97
Interleukin-3 and interferon beta cooperate to induce differentiation of monocytes into dendritic cells with potent helper T-cell stimulatory properties. Blood (2002) 0.97
Tissue factor-dependent procoagulant activity of isolated human hepatocytes: relevance to liver cell transplantation. Liver Transpl (2007) 0.96
Critical role of interleukin 5 and eosinophils in concanavalin A-induced hepatitis in mice. Gastroenterology (2002) 0.96
Trypanosoma cruzi down-regulates lipopolysaccharide-induced MHC class I on human dendritic cells and impairs antigen presentation to specific CD8(+) T lymphocytes. Int Immunol (2002) 0.96
IL-12 and type I IFN response of neonatal myeloid DC to human CMV infection. Eur J Immunol (2009) 0.95
Cellular mechanisms underlying acute graft rejection: time for reassessment. Curr Opin Immunol (2007) 0.95
Immune response to vaccine adjuvants during the first year of life. Vaccine (2012) 0.94
Variables to be controlled in the assessment of blood innate immune responses to Toll-like receptor stimulation. J Immunol Methods (2011) 0.94